Sleep Disordered Breathing (SDB) Prevalence and Cardiovascular Outcomes of Myocardial Infarction (MI) Survivors

NAActive, not recruitingINTERVENTIONAL
Enrollment

2,007

Participants

Timeline

Start Date

April 11, 2019

Primary Completion Date

January 11, 2024

Study Completion Date

September 30, 2024

Conditions
Acute Myocardial InfarctionSleep Apnea
Interventions
DIAGNOSTIC_TEST

Polygraphy

"The polygraphy consists of recording during sleep, respiratory flow by mean of a nasal cannula, respiratory movement by mean of a thoracic belt with inductance plethysmography, blood oxygenation and heartbeats by a fingertip transcutaneous oxymetry.~Starting and ending of the recording will be programmed based on patient interview regarding usual sleep hours.~Polygraphy data are anonymized before being sent to the Cloud and therefore to the core lab.~Polygraphic data will be scored in centralized manner.~Results of the polygraphy will be sent to the cardiology department with advice for treatment and follow-up.~If necessary, the core-lab will provide tele-counseling regarding SDB management."

Trial Locations (1)

Unknown

Hôpital Bichat, AP-HP, Paris

All Listed Sponsors
collaborator

National Research Agency, France

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT04064593 - Sleep Disordered Breathing (SDB) Prevalence and Cardiovascular Outcomes of Myocardial Infarction (MI) Survivors | Biotech Hunter | Biotech Hunter